Immuno-Oncology Development Trends and Market Opportunities
Immuno-oncology (IO) is the treatment of cancer with therapies that stimulate or suppress the bodys own immune system. Several distinct modalities of IO therapy exist, including bispecific T-cell engaging monoclonal antibodies, cellular immunotherapy and adoptive cellular therapy, cancer vaccines, checkpoint modulating monoclonal antibodies, and oncolytic viruses.
View full press release